Goldman Sachs
ZOM

Goldman Sachs’s Zomedica Corp. ZOM Stock Holding History

Goldman Sachs’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,598
Closed -$2K – 6401
2024
Q3 		$2K Buy
+14,598
New +$2.05K ﹤0.01% 5767
2024
Q2 		– Sell
-16,391
Closed -$2.39K – 6080
2024
Q1 		$2.39K Buy
+16,391
New +$2.29K ﹤0.01% 5487
2023
Q4 		– Sell
-19,975
Closed -$3.34K – 6000
2023
Q3 		$3.34K Buy
+19,975
New +$3.88K ﹤0.01% 5458
2023
Q2 		– Sell
-18,596
Closed -$3.94K – 6302
2023
Q1 		$3.94K Buy
+18,596
New +$4.56K ﹤0.01% 5813
2022
Q3 		– Sell
-11,560
Closed -$3K – 6862
2022
Q2 		$3K Sell
11,560
-676,155
-98% -$172K ﹤0.01% 6384
2022
Q1 		$231K Sell
687,715
-93,487
-12% -$30.6K ﹤0.01% 5809
2021
Q4 		$239K Buy
781,202
+211,753
+37% +$95.4K ﹤0.01% 5797
2021
Q3 		$298K Buy
569,449
+16,688
+3% +$9.85K ﹤0.01% 5506
2021
Q2 		$460K Sell
552,761
-375,066
-40% -$349K ﹤0.01% 5272
2021
Q1 		$1.47M Buy
+927,827
New +$1.52M ﹤0.01% 4297
2019
Q3 		– Sell
-204,999
Closed -$47K – 5489
2019
Q2 		$47K Buy
204,999
+177,760
+653% +$53.9K ﹤0.01% 5014
2019
Q1 		$10K Buy
+27,239
New +$24K ﹤0.01% 5068

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs's ZOM Position: Q4 2024 in Review

Goldman Sachs sold out of Zomedica Corp. (ZOM) in Q4 2024, closing a stake of 14,598 shares — an estimated $2K sold.

Goldman Sachs first reported a position in ZOM in Q1 2019 and held it in 12 quarters. The position peaked at $1.47M in Q1 2021. 93 funds tracked by Wall St. Rank hold ZOM as of Q4 2024.

  • Goldman Sachs reported no remaining Zomedica Corp. position as of Q4 2024 after selling out during the quarter.
  • Goldman Sachs sold 14,598 Zomedica Corp. shares in Q4 2024, an estimated $2K.
  • Goldman Sachs first reported a position in Zomedica Corp. in Q1 2019 and held it in 12 quarters.
  • Goldman Sachs's Zomedica Corp. position peaked at $1.47M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.